BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8790157)

  • 21. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
    Park SC; Jeong SH; Kim J; Han CJ; Kim YC; Choi KS; Cho JH; Lee M; Jung HH; Ki SS; Chang YH; Lee SS; Park YH; Lee KH
    J Med Virol; 2008 Jun; 80(6):960-6. PubMed ID: 18428141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extrahepatic disorders of HCV infection: a distinct entity of B-cell neoplasia?
    Libra M; Polesel J; Russo AE; De Re V; Cinà D; Serraino D; Nicoletti F; Spandidos DA; Stivala F; Talamini R
    Int J Oncol; 2010 Jun; 36(6):1331-40. PubMed ID: 20428756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma: a cross-sectional study in Lyon, France.
    Sève P; Renaudier P; Sasco AJ; Dumontet C; Salles G; Coiffier B; Zoulim F; Broussolle C; Trépo C
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1361-5. PubMed ID: 15618846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.
    Realdon S; Pontisso P; Adami F; Trentin L; Noventa F; Ferrari A; Migliorato I; Gatta A; Alberti A
    J Hepatol; 2001 May; 34(5):723-9. PubMed ID: 11434619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
    Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
    J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of HCV among Yemeni patients with non-Hodgkin's lymphoma at AI-Thawra teaching hospital.
    Salem AK
    Gulf J Oncolog; 2009 Jan; (5):22-9. PubMed ID: 20084782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma--a regional association?
    McColl MD; Singer IO; Tait RC; McNeil IR; Cumming RL; Hogg RB
    Leuk Lymphoma; 1997 Jun; 26(1-2):127-30. PubMed ID: 9250797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy.
    Nosotti L; D'Andrea M; Pitidis A; Pimpinelli F; Dessanti ML; Pisani F; Vignally P; Petti MC
    Scand J Infect Dis; 2012 Jan; 44(1):70-3. PubMed ID: 21905952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma.
    Arican A; Sengezer T; Bozdayi M; Bozkaya H; Uçgül E; Dinçol D; Uzunalimoğlu O
    Med Oncol; 2000 May; 17(2):123-6. PubMed ID: 10871818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Non-Hodgkin's lymphoma and hepatitis C virus infection].
    Ennibi K; Bechade D; Rabhi M; Coutant G; Toloune F; Desrame J; Archane MI; Algayres JP
    Rev Med Interne; 2003 Jul; 24(7):452-8. PubMed ID: 12829218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients.
    El-Sayed GM; Mohamed WS; Nouh MA; Moneer MM; El-Mahallawy HA
    Egypt J Immunol; 2006; 13(1):105-14. PubMed ID: 17974155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus and non-Hodgkin's lymphomas.
    Pozzato G; Mazzaro C; Santini G; Burrone O
    Leuk Lymphoma; 1996 Jun; 22(1-2):53-60. PubMed ID: 8724528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.
    Silvestri F; Pipan C; Barillari G; Zaja F; Fanin R; Infanti L; Russo D; Falasca E; Botta GA; Baccarani M
    Blood; 1996 May; 87(10):4296-301. PubMed ID: 8639788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women.
    Morton LM; Engels EA; Holford TR; Leaderer B; Zhang Y; Zahm SH; Boyle P; Zhang B; Flynn S; Tallini G; Owens PH; Zheng T
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):425-30. PubMed ID: 15006919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryoglobulinaemic membranoproliferative glomerulonephritis and hepatitis C virus infection.
    Mazzaro C; Pozzato G; Zorat F; Panarello G; Silvestri F; Barillari G; Mazzoran L; Baracetti S; Crovatto M; Santini GF; Donadon V; Faccini L; Campanacci L
    Ital J Gastroenterol Hepatol; 1999; 31(1):45-53. PubMed ID: 10091102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France.
    Hausfater P; Cacoub P; Sterkers Y; Thibault V; Amoura Z; Nguyen L; Ghillani P; Leblond V; Piette JC
    Am J Hematol; 2001 Jul; 67(3):168-71. PubMed ID: 11391713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy.
    De Rosa G; Gobbo ML; De Renzo A; Notaro R; Garofalo S; Grimaldi M; Apuzzo A; Chiurazzi F; Picardi M; Matarazzo M; Rotoli B
    Am J Hematol; 1997 Jun; 55(2):77-82. PubMed ID: 9209002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection.
    Ohsawa M; Shingu N; Miwa H; Yoshihara H; Kubo M; Tsukuma H; Teshima H; Hashimoto M; Aozasa K
    Int J Cancer; 1999 Jan; 80(2):237-9. PubMed ID: 9935205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.